Asthma treatment costs the NHS millions each year, with inhalers being a significant part of this expenditure. Dr. Potter highlighted the wide range of inhalers available, from basic bronchodilators ...
Bespak, Orbia Fluor & Energy Materials collaborate to accelerate transition to climate-friendly inhalers: Holmes Chapel, UK Thursday, November 7, 2024, 18:00 Hrs [IST] Bespak, a s ...
Global pharma major Lupin Limited (Lupin) announced its focus on formulating respiratory inhalers by incorporating a propellant with near-zero global warming potential (GWP). This initiative aims to ...
Bespak, a specialist inhalation contract development and manufacturing organisation (CDMO), and Orbia Advance Corporation, S.A.B. de C.V. (BMV: ORBIA*) Fluor & Energy Materials (Koura), a global ...